Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KTTA

Pasithea Therapeutics Corp

May 08 • 04:00PM ET

0.7953

-0.0447 -5.32 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NRXP NERV ADIL ALZN DMAC

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.57	Insider Own	12.28%	Shs Outstand	23.09M	Perf Week	-5.43%
Market Cap	19.84M	Forward P/E	-	EPS next Y	-2.10	Insider Trans	6.99%	Shs Float	21.88M	Perf Month	10.46%
Enterprise Value	-35.42M	PEG	-	EPS next Q	-0.45	Inst Own	73.79%	Short Float	1.04%	Perf Quarter	9.70%
Income	-20.43M	P/S	-	EPS this Y	36.08%	Inst Trans	29.87%	Short Ratio	0.55	Perf Half Y	8.29%
Sales	0.00M	P/B	0.33	EPS next Y	-12.90%	ROA	-53.54%	Short Interest	0.23M	Perf YTD	-38.35%
Book/sh	2.39	P/C	0.36	EPS next 5Y	7.54%	ROE	-58.36%	52W High	2.06 -61.39%	Perf Year	-17.16%
Cash/sh	2.22	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.99%	52W Low	0.28 183.02%	Perf 3Y	-88.78%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.69% 8.57%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	71.88%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.35	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.23	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.35	EPS Q/Q	63.00%	SMA20	5.78%	Beta	0.24	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	2.71%	Rel Volume	0.45	Prev Close	0.84
Employees	5	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-2.41%	Avg Volume	410.90K	Price	0.80
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-338.89% -	Trades		Volume	186,256	Change	-5.32%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)